Progression from F3 to cirrhosis occurred in roughly one year, contrasting STELLAR’s 13% over four years and suggesting trials may underrepresent real-world risk. Among compensated cirrhosis, 29.7% ...

Simple FNI labs pinpoint high‑mortality MASLD fibrosis in type 2 diabetes, challenging FIB‑4 and sharpening MASH liver disease screening. An age-independent liver fibrosis marker outperformed 2 widely ...

Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden ...

A simple formula developed at VCU two decades ago has become a global standard for liver disease detection, helping millions ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Nonalcoholic fatty liver disease fibrosis scores and ...

Repeat fibrosis-4 (FIB-4) scores can be used to identify people at greatest risk for cirrhosis of the liver, new research shows. "Done repeatedly, this test can improve prediction capacity to identify ...

In this issue of Polish Archives of Internal Medicine, Abu Baker et al 5 add a novel and clinically useful perspective to this debate by showing that elevated FIB‑4 may function as a marker of ...

Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study. The risk of liver cirrhosis increases if ...